Skip to main content
Equibles

MORGAN STANLEY

Position in MLTX — MoonLake Immunotherapeutics

CIK 895421 NEW YORK, NY
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,973,328
-$480,612 QoQ
Shares Held
563,602
-8.3% QoQ
Ownership
0.662%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 172 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. MLTX ranks #136 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in MLTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,973,328 563,602
2026-03-31 $11,453,940 614,482
2025-12-31 $13,767,575 1,044,581
2025-09-30 $1,840,213 256,655
2025-06-30 $2,040,878 43,239
2025-03-31 $2,122,708 54,331
2024-12-31 $2,552,844 47,144
2024-09-30 $6,584,748 130,598
2024-06-30 $3,035,111 69,027
2024-03-31 $11,511,810 229,182
2023-12-31 $4,016,778 66,514
2023-09-30 $538,707 9,451
2023-06-30 $8,130,675 159,425
2023-03-31 $695,580 32,519
2022-12-31 $287,332 27,365
2022-09-30 $24,056 3,100